Home / Encyclopedia / Recovery & Healing / BPC-157 vs TB-500

⚖️ Recovery & Healing

BPC-157 vs TB-500

How do BPC-157 and TB-500 compare for Recovery & Healing research? Side-by-side evidence, molecular profile, EU legal status and COA-verified supplier prices — never dosing advice.

At a glance

BPC-157

🧬 Recovery & Healing

EVIDENCE BASEStrong

SEQUENCE

15 amino acids

1419.5 g/mol

CAS

137525-51-0

EU STATUS

Research only

WADA

Prohibited S0

MIN PURITY

≥98% HPLC

Molecular weight

1419.5 g/mol

CAS number

137525-51-0

PRICE FROM

€18.85 · 19 EU vendors

View prices →

TB-500

🧬 Recovery & Healing

EVIDENCE BASEModerate

CLASS

TB-4 fragment

~889 g/mol (frag)

EU STATUS

Research only

WADA

Prohibited S2

ROUTE

Subcutaneous / IM

MIN PURITY

≥98% HPLC

Molecular weight

~889 g/mol (frag)

PRICE FROM

€22.63 · 20 EU vendors

View prices →

Which fits which research target?

Both BPC-157 and TB-500 sit within Recovery & Healing research but are studied for different primary signals. Neither is an approved medicine — compare the evidence, not marketing claims.

PRIMARY RESEARCH SIGNAL

BPC-157

Tendon & ligament healing

TB-500

Tissue repair & wound healing

⚠ Neither BPC-157 nor TB-500 is an approved medicine. All comparisons here are research observations, not usage, dosing or efficacy recommendations.

What the research shows

BPC-157

EVIDENCE SUMMARY

STRONG

Tendon & ligament healing — Multiple animal studies show significantly accelerated tendon-to-bone healing and ligament regeneration. The most replicated finding.

STRONG

Gastrointestinal protection — Protective effects on gut mucosa, ulcer healing and IBD models in rodents. Where BPC-157 research originated and is most robust.

MODERATE

Angiogenesis — Upregulates VEGFR2 and promotes blood vessel formation. Proposed mechanism behind many healing effects.

ANIMAL ONLY

Neurological & systemic recovery — Interesting animal data but no published human clinical trials as of mid-2026. Human extrapolation is speculative.

TB-500

EVIDENCE SUMMARY

MODERATE

Tissue repair & wound healing — Animal data showing accelerated wound closure, muscle and tendon repair through actin regulation and cell migration.

MODERATE

Angiogenesis & cardiac repair — Studies in cardiac injury models show improved vascularisation and reduced scarring. Promising but animal-stage.

LIMITED

Hair growth, anti-inflammatory — Preliminary animal signals. Human data essentially absent.

ANIMAL ONLY

Systemic recovery — No completed human clinical trials. Popular in veterinary (equine) research.

Compare prices across EU suppliers

Compare BPC-157 across EU suppliers

19 EU vendors · COA · from €18.85

View prices →

Compare TB-500 across EU suppliers

20 EU vendors · COA · from €22.63

View prices →

Frequently asked questions

Is BPC-157 or TB-500 better? ▾

Neither is an approved medicine, and “better” depends on the research target. BPC-157 is most associated with Tendon & ligament healing, while TB-500 is studied for Tissue repair & wound healing. Compare the evidence tiers and COA-verified EU pricing above rather than assuming one is superior. This is not a usage recommendation.

Why compare BPC-157 and TB-500? ▾

Both are studied within Recovery & Healing research through different mechanisms, so researchers often weigh them against each other. This page sets their evidence, molecular profile, EU legal status and supplier pricing side by side.

Which is cheaper in the EU, BPC-157 or TB-500? ▾

Prices vary by supplier, vial size and COA status. BPC-157 is listed from €18.85 across 19 COA-verified EU vendors; TB-500 from €22.63 across 20. Open the price pages above to compare current listings — nobody pays us for placement.

BPC-157 vs TB-500

At a glance

BPC-157

TB-500

Which fits which research target?

What the research shows

BPC-157

TB-500

Compare prices across EU suppliers

Compare BPC-157 across EU suppliers

Compare TB-500 across EU suppliers

Frequently asked questions

Read the full guides

BPC-157

TB-500